Literature DB >> 16529749

Alpha-tocopheryl succinate induces DR4 and DR5 expression by a p53-dependent route: implication for sensitisation of resistant cancer cells to TRAIL apoptosis.

Marco Tomasetti1, Ladislav Andera, Renata Alleva, Battista Borghi, Jiri Neuzil, Antonio Procopio.   

Abstract

We evaluated the ability of alpha-tocopheryl succinate (alpha-TOS) to sensitise TRAIL-resistant malignant mesothelioma (MM) cells to TRAIL-induced apoptosis. We show that alpha-TOS activates expression of DR4/DR5 in a p53-dependent manner and re-establishes sensitivity of resistant MM cells to TRAIL-mediated apoptosis, as documented in p53wt MM cells but not in their p53null counterparts. MM cells selected for TRAIL resistance expressed low cell surface levels of DR4 and DR5. Treatment with sub-lethal doses of alpha-TOS restored expression of DR4 and DR5. The ability of alpha-TOS to modulate expression of pro-apoptotic genes may play a role in sensitisation of tumour cells to immunological stimuli.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16529749     DOI: 10.1016/j.febslet.2006.02.054

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Garcinol potentiates TRAIL-induced apoptosis through modulation of death receptors and antiapoptotic proteins.

Authors:  Sahdeo Prasad; Jayaraj Ravindran; Bokyung Sung; Manoj K Pandey; Bharat B Aggarwal
Journal:  Mol Cancer Ther       Date:  2010-04-06       Impact factor: 6.261

Review 2.  Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy.

Authors:  Xiaoyun Dai; Jingwen Zhang; Frank Arfuso; Arunachalam Chinnathambi; M E Zayed; Sulaiman Ali Alharbi; Alan Prem Kumar; Kwang Seok Ahn; Gautam Sethi
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-07

3.  Triptolide sensitizes TRAIL-induced apoptosis in prostate cancer cells via p53-mediated DR5 up-regulation.

Authors:  Hu Xiaowen; Sun Yi
Journal:  Mol Biol Rep       Date:  2012-06-17       Impact factor: 2.316

Review 4.  Combination of physical activity, nutrition, or other metabolic factors and vaccine response.

Authors:  Kenneth W Hance; Connie J Rogers; Stephen D Hursting; John W Greiner
Journal:  Front Biosci       Date:  2007-09-01

5.  Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: Evidence for an essential role of reactive oxygen species.

Authors:  Supachai Yodkeeree; Bokyung Sung; Pornngarm Limtrakul; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

6.  Capsazepine, a TRPV1 antagonist, sensitizes colorectal cancer cells to apoptosis by TRAIL through ROS-JNK-CHOP-mediated upregulation of death receptors.

Authors:  Bokyung Sung; Sahdeo Prasad; Jayaraj Ravindran; Vivek R Yadav; Bharat B Aggarwal
Journal:  Free Radic Biol Med       Date:  2012-08-15       Impact factor: 7.376

7.  Hypoxia-induced decrease in p53 protein level and increase in c-jun DNA binding activity results in cancer cell resistance to etoposide.

Authors:  Jean-Philippe Cosse; Marie Ronvaux; Noëlle Ninane; Martine J Raes; Carine Michiels
Journal:  Neoplasia       Date:  2009-10       Impact factor: 5.715

8.  Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions.

Authors:  Hongqin Zhuang; Weiwei Jiang; Xiangyu Zhang; Fan Qiu; Ziyi Gan; Wei Cheng; Jing Zhang; Shengwen Guan; Bo Tang; Qilai Huang; Xinhua Wu; Xiaofeng Huang; Wenhui Jiang; Qingang Hu; Min Lu; Zi-Chun Hua
Journal:  J Mol Med (Berl)       Date:  2012-09-05       Impact factor: 4.599

9.  TRAIL and vitamins: opting for keys to castle of cancer proteome instead of open sesame.

Authors:  Ammad Ahmad Farooqi; Shahzad Bhatti; Muhammad Ismail
Journal:  Cancer Cell Int       Date:  2012-06-06       Impact factor: 5.722

Review 10.  Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II.

Authors:  Jiri Neuzil; Jeffrey C Dyason; Ruth Freeman; Lan-Feng Dong; Lubomir Prochazka; Xiu-Fang Wang; Immo Scheffler; Stephen J Ralph
Journal:  J Bioenerg Biomembr       Date:  2007-02       Impact factor: 3.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.